Bone Diseases  >>  risedronate delayed-release  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
risedronate delayed-release / Generic mfg.
NCT00918749: Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women

Completed
2
205
US
150 mg, 75 mg, 100 mg
Warner Chilcott
Postmenopausal Osteoporosis
10/09
10/09

Download Options